Innovative Immunity Solutions OM Pharma specializes in bacterial lysates to enhance immune health, presenting opportunities to collaborate with healthcare providers seeking preventative therapies for respiratory and urinary infections.
Global Presence With products distributed across over 100 countries, OM Pharma offers vast market reach, ideal for partners interested in expanding their portfolio internationally with biotech and immunology-focused products.
Tech-Driven Distribution Recent launches like Med Hub leveraging AI and dark warehousing demonstrate OM Pharma's commitment to cutting-edge logistics, presenting potential for integrations, supply chain partnerships, or distribution capacity enhancements.
Strategic Acquisition Backing Having been acquired by Vifor Pharma, OM Pharma benefits from established corporate support and financial stability, offering confidence for joint ventures or co-marketing opportunities.
Financial Stability With revenues estimated between 50 million and 100 million USD, OM Pharma shows solid market presence in the biotech space, indicating readiness for scaling collaborations, licensing deals, or joint research initiatives.